Skip navigation
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Prevention Among Injection Drug Users

 IDU HIV Prevention
 IDU Home
General Information
 Fact Sheet Series:
 Syringe Disinfection for Injection Drug Users
 Viral Hepatitis
 Substance Abuse
Treatment
 Criminal Justice
 Access to Sterile Syringes
Comprehensive
Approach Brochure
Comprehensive
Approach Document
 Dear Colleague Letters
Explore IDU Topics
Other Publications
 Order Printed Materials
Comments
   

U.S. Department of Health and Human Services

Viral Hepatitis and Injection Drug Users

In the United States, viral hepatitis is an important public health problem because it causes serious illness, it affects millions, and it has a close connection with HIV. This series of fact sheets addresses viral hepatitis, particularly hepatitis B and C – two important blood-borne infections that have a major impact on injection drug users (IDUs).


Viral Hepatitis and Injection Drug Users
Millions of Americans have viral hepatitis. It is a particularly significant problem among injection drug users (IDUs). Growing awareness of this problem is leading to new initiatives, but efforts to prevent these diseases and reduce their medical, financial, and social costs face challenges. (PDF 63 KB, 6 pages)

Medical Management of Chronic Hepatitis B and Chronic Hepatitis C
Many individuals who become infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) develop chronic liver disease that can gradually lead to serious liver damage. Medical management involves periodic monitoring, abstinence from alcoholic beverages, and for some patients, antiviral therapy. (PDF 46 KB, 4 pages)

Vaccines to Prevent Hepatitis A and Hepatitis B
Hepatitis A and B can be prevented through immunization. Awareness of the importance of immunizing against these diseases is growing, and new initiatives are capitalizing on this interest. No vaccine to prevent hepatitis C is available. (PDF 47 KB, 4 pages)

Hepatitis C Virus and HIV Coinfection
Coinfection with HIV and hepatitis C virus (HCV) is a significant problem, especially among injection drug users (IDUs). Care for individuals living with both diseases is complex. Coinfected IDUs can be treated successfully, although the caregiving team should have expertise in liver disease, HIV, and addiction. (PDF 45 KB, 4 pages)

Viral Hepatitis and the Criminal Justice System
The unique circumstances of the criminal justice environment create opportunities to reach an underserved population with viral hepatitis prevention and treatment services. However, correctional facilities must grapple with several issues, including uncertainty about who will pay for these services, a lack of screening and treatment guidelines, and a need for staff training. (PDF 43 KB, 4 pages)

 

 designed by mike oppenheimer  
This document produced by the Academy for Educational Development, with funding from CDC.
Adobe Acrobat (TM) Reader v5.0 or higher needs to be installed on your computer in order to read documents in PDF format. Download the Adobe Acrobat (TM) Reader.
   
Go to top
Last Updated: October 3, 2002

Centers for Disease Control & Prevention
National Center for HIV, STD, and TB Prevention
Divisions of HIV/AIDS Prevention

Privacy Policy | Accessibility

FirstGov - The First Click to the U.S. Government